Hangzhou Coco Healthcare Products Co.Ltd. (301009) — Cash Flow Reinvestment Rate
Hangzhou Coco Healthcare Products Co.Ltd. (301009) has a Cash Flow Reinvestment Rate of 3.46x as of June 2025, reinvesting CN¥42.27 Million (capex CN¥4.26 Million plus investments CN¥-38.01 Million) from operating cash flow of CN¥12.21 Million. Check Hangzhou Coco Healthcare Products Co.Ltd (301009) cash earnings ratio to evaluate the quality of earnings relative to operating cash generation.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Hangzhou Coco Healthcare Products Co.Ltd. Cash Flow Reinvestment Rate (2017–2024)
Historical reinvestment intensity for Hangzhou Coco Healthcare Products Co.Ltd. across 7 annual periods. Explore cash flow to debt ratio of Hangzhou Coco Healthcare Products Co.Ltd to assess how comfortably operating cash covers total debt obligations.
Annual Cash Flow Reinvestment Rate for Hangzhou Coco Healthcare Products Co.Ltd. (2017–2024)
Year-by-year capital reinvestment analysis for Hangzhou Coco Healthcare Products Co.Ltd.. For live market cap and broader valuation context, see Hangzhou Coco Healthcare Products Co.Ltd stock valuation.
| Year | Reinvestment Rate | Total Reinvested (CNY) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2024 | 6.35x | CN¥332.91 Million | CN¥52.44 Million | CN¥75.35 Million | ▲ +938.0% |
| 2023 | 0.61x | CN¥139.26 Million | CN¥227.70 Million | CN¥66.01 Million | ▼ -91.3% |
| 2021 | 7.03x | CN¥355.37 Million | CN¥50.53 Million | CN¥240.45 Million | ▲ +423.2% |
| 2020 | 1.34x | CN¥532.18 Million | CN¥395.86 Million | CN¥220.71 Million | ▲ +14.8% |
| 2019 | 1.17x | CN¥261.58 Million | CN¥223.33 Million | CN¥125.86 Million | ▲ +49.1% |
| 2018 | 0.79x | CN¥89.78 Million | CN¥114.26 Million | CN¥89.78 Million | ▲ +11.4% |
| 2017 | 0.71x | CN¥77.41 Million | CN¥109.74 Million | CN¥77.41 Million | — |